BE848111A - Agent antihemophilique et son procede de preparation, - Google Patents

Agent antihemophilique et son procede de preparation,

Info

Publication number
BE848111A
BE848111A BE172170A BE172170A BE848111A BE 848111 A BE848111 A BE 848111A BE 172170 A BE172170 A BE 172170A BE 172170 A BE172170 A BE 172170A BE 848111 A BE848111 A BE 848111A
Authority
BE
Belgium
Prior art keywords
preparation process
antihemophilic
agent
antihemophilic agent
preparation
Prior art date
Application number
BE172170A
Other languages
English (en)
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE848111A publication Critical patent/BE848111A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424Serine endopeptidases (3.4.21)
    • C12N9/647Blood coagulation factors not provided for in a preceding group or according to more than one of the proceeding groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48Reproductive organs
    • A61K35/50Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745Blood coagulation or fibrinolysis factors
    • C07K14/755Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827Proteins from mammals or birds
    • Y10S530/85Reproductive organs or embryos
    • Y10S530/851Placenta; amniotic fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Reproductive Health (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
BE172170A 1975-11-07 1976-11-08 Agent antihemophilique et son procede de preparation, BE848111A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2550011A DE2550011C2 (de) 1975-11-07 1975-11-07 Verfahren zur Herstellung eines antihämophilen Mittels

Publications (1)

Publication Number Publication Date
BE848111A true BE848111A (fr) 1977-05-09

Family

ID=5961172

Family Applications (1)

Application Number Title Priority Date Filing Date
BE172170A BE848111A (fr) 1975-11-07 1976-11-08 Agent antihemophilique et son procede de preparation,

Country Status (20)

Country Link
US (1) US4067964A (de)
JP (1) JPS6029362B2 (de)
AT (1) AT358737B (de)
AU (1) AU500621B2 (de)
BE (1) BE848111A (de)
CA (1) CA1077393A (de)
CH (1) CH630805A5 (de)
DE (1) DE2550011C2 (de)
DK (1) DK502176A (de)
ES (1) ES452923A1 (de)
FI (1) FI763165A (de)
FR (1) FR2330408A1 (de)
GB (1) GB1563009A (de)
IL (1) IL50847A (de)
IT (1) IT1063617B (de)
LU (1) LU76145A1 (de)
NL (1) NL7612139A (de)
NO (1) NO763776L (de)
SE (1) SE7612396L (de)
ZA (1) ZA766647B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1981002105A1 (en) * 1980-01-28 1981-08-06 Baxter Travenol Lab Therapeutic compositions & methods for manufacture and use
US4459288A (en) * 1981-05-11 1984-07-10 Baxter Travenol Laboratories, Inc. Therapeutic blood clotting factor compositions and their use
DE3625090A1 (de) * 1986-07-24 1988-01-28 Behringwerke Ag Mittel zur therapie faktor viii-resistenter haemophilie a und verfahren zu seiner herstellung
CA1339946C (en) * 1987-03-31 1998-07-07 Michael J. Griffith Ultrapurification process for polypeptides
JP2931319B2 (ja) * 1989-03-29 1999-08-09 吉富製薬株式会社 血液凝固第▲viii▼因子の製造法
JP3180824B2 (ja) * 1991-08-30 2001-06-25 シスメックス株式会社 血液凝固試薬
IL156842A0 (en) * 2001-02-05 2004-02-08 Novo Nordisk Healthcare Ag Combined use of factor vii polypeptides and factor ix polypeptides

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3862002A (en) * 1962-05-08 1975-01-21 Sanfar Lab Inc Production of physiologically active placental substances
BE713764A (de) * 1967-05-01 1968-09-16 Baxter Travenol Lab
BE787961A (fr) * 1971-08-24 1973-02-26 Behringwerke Ag Procede d'isolement d'une matiere thromboplastique et medicament contenant ladite matiere
DE2262520C3 (de) * 1972-12-20 1987-02-12 Miles Laboratories, Inc., Elkhart, Ind. Verfahren zur Herstellung eines lyophilisierten, lagerfähigen Konzentrats aus menschlichem Plasma

Also Published As

Publication number Publication date
NO763776L (de) 1977-05-10
CA1077393A (en) 1980-05-13
DE2550011A1 (de) 1977-05-12
FR2330408A1 (fr) 1977-06-03
FR2330408B1 (de) 1980-03-14
AU500621B2 (en) 1979-05-24
IL50847A (en) 1980-01-31
JPS5257310A (en) 1977-05-11
ES452923A1 (es) 1977-11-16
NL7612139A (nl) 1977-05-10
DE2550011C2 (de) 1982-11-25
CH630805A5 (de) 1982-07-15
DK502176A (da) 1977-05-08
ZA766647B (en) 1977-10-26
JPS6029362B2 (ja) 1985-07-10
IL50847A0 (en) 1977-01-31
LU76145A1 (de) 1977-06-03
SE7612396L (sv) 1977-05-08
GB1563009A (en) 1980-03-19
US4067964A (en) 1978-01-10
AU1934176A (en) 1978-05-11
FI763165A (de) 1977-05-08
IT1063617B (it) 1985-02-11
ATA819476A (de) 1980-02-15
AT358737B (de) 1980-09-25

Similar Documents

Publication Publication Date Title
BE857931A (fr) Gel de phospha-alumine et son procede de preparation
FR2320459A1 (fr) Joint coulissant et son procede de realisation
FR2339624A1 (fr) Pullulane reticule et son procede de preparation
BE847090A (fr) 15-steroides, et leur procede de preparation
BE841747A (fr) Ether 1,2,2,2,-tetrafluoroethyl-fluoromethylique, son procede de preparation et son application
BE842182A (fr) Lucknomycine et son procede de preparation
FR2303557A1 (fr) Nouvel antibiotique et son procede de preparation
BE840540A (fr) Procede de preparation de sterol-glycosides aisement absorbables
BE848111A (fr) Agent antihemophilique et son procede de preparation,
BE855092A (fr) 3,5,5-trimethylhexanoyl-ferrcene et son procede de preparation
BE832364A (fr) 17 alpha-hydroxy-1,3,5(10), 15-oestratetraenes et leur procede de preparation
FR2296645A1 (fr) 3a, 5a-cyclo-6b-alkoxy-25-hydroxycholest-22-yne et son procede de preparation
FR2299300A1 (fr) Trihalogeno-1,1,1-methyl-4-pentene-3-ols-2 et leur procede de preparation
FR2319377A1 (fr) Fortimicine c et son procede de preparation
FR2283669A1 (fr) 2-cetoglutarate de vincamine et son procede de preparation
FR2335515A1 (fr) Trimethylphosphiniminodimethylmethylenephosphorane et son procede de preparation
FR2313036A1 (fr) Nouvelles thienyl-prostaglandines, leur procede de preparation et leur application
FR2296646A1 (fr) 3a,5a-cyclo-6Ÿ-oxycholesta-22t,24-diene et son procede de preparation
BE834897A (fr) 3,7 - dimethyl - 3 - hydroxy - 6 - octenenitrile et son procede de preparation
FR2298362A1 (fr) Procede de n
FR2340325A1 (fr) Nouvel antibiotique et son procede de preparation
FR2335214A1 (fr) Pyrrolidones, leur procede de preparation et leur application
BE842064A (fr) Procede de preparation de n-alkylamino-anthraquinones et n,n-dialkylamino-anthraquinones
BE848366A (fr) Nocardicines e et f, et leur procede de preparation,
FR2351936A1 (fr) Cetone s, e-insaturee et son procede de preparation

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: BEHRINGWERKE A.G.

Effective date: 19931130